Dow Down 0.02% Nasdaq Down 0.00%

More On ALIOF

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

Actelion Ltd. (ALIOF)

-Other OTC
116.50 Up 4.31(3.84%) Nov 25, 2:14PM EST
|Pre-Market : NaN
Prev Close:112.19
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:76.89 - 129.25
Volume:0
Avg Vol (3m):1,028
Market Cap:12.95B
P/E (ttm):18.21
EPS (ttm):6.40
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Key Statistics

Forward P/E (1 yr):20.40
P/S (ttm):6.21
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :5.86
Quarterly EPS Est (Sep-14) :1.39
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):3.14

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Actelion Ltd, a biopharmaceutical company, discovers, develops, and commercializes drugs for diseases with unmet medical needs. Its products include Tracleer, a dual endothelin receptor antagonist for the treatment of pulmonary arterial hypertensi... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback